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Conclusions: The presented analytical dose calculation algorithm is 
applicable for any type of heterogeneity. The high calculation speed 
of the algorithm makes it feasible for use in clinical real time- 
treatment planning and thus for improving treatment quality. 
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Purpose/Objective: To evaluate and compare the dosimetric 
parameters of intraoperative treatment plans in prostate seed 
implants performed with loose seed and stranded seed techniques.  
Materials and Methods: Permanent prostate brachytherapy with I-125 
seeds as a monotherapy for patients with low and intermediate risk 
prostate cancer was implemented at our institute in 2009, and since 
then 147 patients have been treated. The first 79 patients were 
implanted with loose seeds (seedSelect, Nucletron) and the next 68 
patients with stranded seeds (IsoSeed, Bebig). Loose seeds (LS) were 
delivered automatically with the seedSelectron system, while 
stranded seeds (SS) were placed into the prostate manually. For 
treatment planning the SPOT PRO 3.1 (Nucletron) software was used 
for all patients. The number and positions of seeds were calculated 
with an inverse dose optimization algorithm (IPSA) in the pre-implant 
plan. Then, the seeds were implanted under transrectal ultrasound 
guidance, and their real positions were updated in live planning. The 
prescribed dose was 145 Gy. Dose-volume histograms were calculated 
and volumetric parameters were used to evaluate the plans. V100 (%), 
DHI, D90 (Gy) and COIN were determined for the prostate, while Dmax 
(%), D0.1cm3 (%), D10 (%), D30 (%) for the urethra, and Dmax (%), 
D0.1cm3 (Gy), D2cm3 (Gy), D10 (%) for the rectum. Means and standard 
deviations were calculated and compared for both intervention 
groups. 
Results: On average, 54 and 47 seeds were implanted in the prostate 
with individual median seed activities of 0.49 and 0.56 mCi for LS and 
SS technique, respectively. The median needle number was 15 and 17, 
correspondingly. The mean prostate volumes were practically 
identical (33.4 vs. 33.9 cm3). The dose coverage was similar (V100: 
96% vs. 97%, D90: 167 Gy vs.169 Gy) in the two groups, and the dose 
homogeneity was identical (DHI: 0.39). The conformity of dose 
distributions was better for LS (COIN: 0.70 vs. 0.65). Regarding the 
dose to urethra all dosimetric parameters were significantly lower 
(p<0.05) for LS (Dmax: 138% vs. 154%, D0.1cm3: 126 vs. 140 %, D10: 125 
vs. 136 % and D30: 119 vs. 128 %). The rectum received less dose with 
the LS technique (Dmax: 101% vs. 112 %, D2cm3: 82 Gy vs. 97 Gy, 
D0.1cm3 :127 vs. 143 Gy, and D10: 75% vs. 86%) (p<0.05 for all). 
Conclusions: In permanent prostate seed brachytherapy the dose to 
urethra and rectum is less with LS technique compared to SS 
technique in the intraoperative plans. Moreover, the conformity of 
dose distributions is also better with LS along with the same 
homogeneity of dose distributions. Probably the more flexible loading 
pattern for LS technique results in the more favourable dose 
distributions.  
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Purpose/Objective: A survey of high dose rate (HDR) brachytherapy 
quality control (QC) procedures undertaken at radiotherapy centres in 
the United Kingdom (UK) is reported [1]. Published recommendations 
and guidance for HDR QC are also reviewed and compared to current 
UK practice. Recent changes in clinical brachytherapy techniques and 
the impact on required QC is discussed. Modern methods to determine 
optimum quality checking processes are indicated. This work is 
conducted in the context of the recent 'point/counterpoint' debate in 
Medical Physics that 'QA procedures in radiation therapy are outdated 
and negatively impact the reduction of errors' [2] and a review of the 
dosimetric accuracy in HDR [3]. 
[1] AL Palmer, M Bidmead, A Nisbet. J Contemp Brachy 2013 (in press) 
[2] HI Amols, EE Klein. Med Phys 2011; 38: 5835-5837  
[3] A Palmer, D Bradley, A Nisbet. J Contemp Brachy 2012; 4: 81-91  
Materials and Methods: All UK radiotherapy centres were asked to 
participate in a survey of their approach and practice for HDR 
brachytherapy QC. This included guidance used, frequencies and 
tolerance values for individual QC tests. A comprehensive evaluation 
of responses was conducted detailing popularity of tests, and the 
average and range values of testing and tolerance. A literature search 
was conducted on general guidance, specific QC techniques in both 
brachytherapy and teletherapy, and on risk-based systems for quality 
assurance.  
Results: Survey data was acquired from 31 UK radiotherapy centres 
and statistical analysis of responses performed. 45 possible individual 
QC tests were identified. There was general agreement on 
measurement frequency and tolerance for key QC tests, e.g. 
measurement of source position in a straight catheter, checked daily 
and with a 1.0mm tolerance in most centres. There was disagreement 
on a number of tests, e.g. the need for regular x-ray imaging of 
applicators. There was absence of tests that may be deemed 
necessary for modern brachytherapy practice, e.g. confirmation of 
planned and delivered dose distributions. There is likely a need to 
move from a device-centred to a system-centred approach, using risk-
based assessment methods to determine required QC testing, with 
emphasis on clinical processes rather than simple device operation. 
Table 1 provides sample key results from the work. 
 Conclusions: The only contemporary benchmark survey of HDR QC 
practice has been undertaken. The outcome of this work is a review of 
current practice against available recommendations, relevant recent 
changes in clinical brachytherapy techniques, and the use of modern 
quality process assessments. Recommendations for appropriate, 
optimised QC for HDR brachytherapy are made. 
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Purpose/Objective: Since several years, Co-60 HDR afterloading 
sources are commercially available. The long half-life of Co-60 
together with its comparable dose distributions to Ir-192 makes this 
type of sources economically attractive, especially in developing 
countries. However up to date protocols for brachytherapy dosimetry 
provide no explicit guidelines for verification of Co-60 source 
calibration by the clinical physicist. The purpose of this work was 
twofold: first, the verification procedures recommended for Ir-192 in 
three existing dosimetry protocols were applied to both Co-60 and Ir-
192 sources in order to test their applicability with Co-60 sources. 
Second, the evaluation of the experiments was performed together 
with medical physicists trained in a joint education program between 
Universities in Germany and Bangladesh. Purpose of this step was to 
add practical experience in Brachytherapy physics, a subject for which 
the Bangladesh University so far has only very little access to 
treatment facilities. 
Materials and Methods: Three existing dosimetry protocols (IAEA-
TECDOC-1274, DIN 6809-2, AAPM Report 41) were applied to Co-60 and 
Ir-192 sources to measure reference air kerma rate with ionization 
chambers using the procedures recommended for Ir-192. Wherever the 
protocols give no correction factors for the chamber readings from Co-
60 sources, equivalent factors from literature were used. Verification 
measurements were performed with three different experimental 
methods (with a cylindrical ionization chamber both in a solid 
phantom and free in air, and with a well chamber) and evaluated with 
all three protocols. The measurements were performed at two 
hospitals in Germany, and evaluated in parallel in by the groups in 
Germany and Bangladesh. The results are compared to the reference 
air kerma rates given in the source certificates. 
Results: The measurements with all protocols and methods are in 
good agreement both for Ir-192 and Co-60. The measured air kerma 
rates show deviations from the certificate values smaller than 1.2% for 
Ir-192 and 2.5% for Co-60-Sources. The measurements with the well 
chamber show the lowest deviations from the certificate value. The 
results of the experiments were published both in a German and in an 
Indian medical physics journal. 
Conclusions: Air kerma rate measurements for Co-60 HDR sources 
using the existing protocols are possible with accuracy sufficient to 
verify source calibration even though the protocols are not specifically 
designed for Co-60 measurements. The existing protocols for 
brachytherapy dosimetry are outdated. New protocols are desirable, 
based on measurements with ionization chambers calibrated in 
absorbed dose to water and providing the complete measurement 
procedure and correction formalism also for Co-60 sources. Joint 
evaluation of experiments by physicist at a teaching institution and 
physicists in training at a second institution can provide a valuable 
means to disseminate experience to institutions with missing 
experimental resources. 
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Purpose/Objective: A water equivalence study of different human 
tissue compositions is interesting to validate the segmentation 
schemes employed in contemporary treatment planning systems with 
advanced dose calculation algorithms, and assist their benchmarking 
against TG43 based calculations in water. 
Materials and Methods: Monte Carlo simulations were performed for a 
point 192Ir source centered in homogeneous 50cm radius spheres of 
different tissue compositions taken from Schneider et al (2000) and 
the AAPM TG186 report. Tissue density was set to 1 in all simulations. 
Dose was approximated by collision kerma and both water and tissue 
kerma in tissue (i.e. Kw,t and Kt,t) were scored using the *F2 surface 
flux tally. Results are expressed as % differences of Kw,t with 
homogeneous water (Kw,w) to quantify differences in attenuation and 
scatter, as well as % differences between Kt,t and Kw,w to quantify 
the combined effect of the attenuation and differences in mass 
energy absorption. 
Results: 
 
  
When the effect of density is ruled out, differences in electron density 
and Zeff between air and water translate to negligible differences in 
attenuation (Kw,air is within 1% with Kw,w in contrast to Kair,air 
which is 10% lower due to the lower mass energy absorption of air). 
Dosimetric differences between lung and water are negligible 
regardless of kerma reporting in lung or water, albeit positive in the 
former case and negative in the latter. For soft tissue materials, Kw,t 
reporting would yield significant differences from water for high 
adipose content (lower O weight) only at increased distances. Kt,t 
reporting would yield negligible differences from water for all 
materials and distances. The connective and mean soft tissues all 
appear dosimetrically equivalent to water regardless of reporting Kw,t 
or Kt,t, except for mean adipose. Skeletal tissues present increasing 
differences from water with increasing proportion of osseous tissue to 
bone marrow, with negative differences for Kw,bone and positive for 
Kbone,bone. 
Conclusions: Lung and average soft tissue materials set forth by the 
AAPM TG186 are water equivalent for the 192Ir energies regardless of 
kerma reporting material. Departure from water equivalence is only 
observed when Kw,t is reported and only for large tissue thickness. 
Kerma reporting material also affects the differences relative to 
water for skeletal materials. Tissue density is the determining 
parameter for individualized 192Ir patient dosimetry. A method for 
stoichiometric CT calibration is not required unless reporting water 
kerma in the inhomogeneous geometry is of the essence. 
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Purpose/Objective: In permanent I-125 seed implants of the prostate, 
the quality of the implant depends, amongst other factors, on the 
quality of the image modality used during implantation. The image 
modality most frequently used in the OR is TRUS. Since March 2009 a 
new type of TRUS probe is introduced in our clinic. This is a dual 
sagittal crystal probe (DSCP) with a transversal crystal in between, 
instead of the conventional single sagittal crystal probe (SSCP) with a 
transversal crystal in front. In a retrospective study it was 
investigated whether a longer sagittal view using a DSCP allowed for 
more accurate online-planning in I-125 permanent implant 
